Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-23

Clinical Trial Update: 17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing 17% salicylate versus 17% salicylate-ethyl pyruvate for plantar warts; the status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 17% Salicylate
  • 17% Salicylate-Ethyl Pyruvate

Snippet

Sponsor: Grossman, Michael, D.P.M. | Conditions: Warts | Phase 4 | Status: UNKNOWN